CJC 1295 Ipamorelin Australia: Buy CJC-1295 Ipamorelin Online

Shop the CJC 1295 Ipamorelin 10 mg Blend With Lot Data and Chemical Identity

Order the blend when a protocol runs Mod GRF (1-29) and ipamorelin at equal weight and one vial is easier to prepare than two. It is packed in Australia, both peaks are checked on every lot, and the per-component maths is set out below.

What Is CJC 1295 Ipamorelin?

CJC 1295 ipamorelin is a two-peptide research blend that pairs a GHRH analogue with an agonist of the ghrelin receptor, so a single preparation presses both of the pituitary's main release buttons for growth hormone at the same moment. Each component has its own page: the Mod GRF 1-29 single vial covers the GHRH side, and the selective ghrelin agonist on its own covers the other. This section is about why the two are put together.

Why the two pathways are paired

The receptors sit on the same somatotroph cells but talk to them in different languages. The GHRH receptor couples to Gs and raises cyclic AMP, which primes the cell and builds its supply of growth hormone. GHS-R1a couples to Gq, releasing calcium from internal stores and activating protein kinase C, which pushes stored granules out. One signal loads the cell; the other pulls the trigger. Ghrelin-type agonists also act upstream in the hypothalamus, where they encourage GHRH release and blunt the braking effect of somatostatin.

That is why the combination produces more than the sum of its parts. Cyril Bowers and colleagues showed it in healthy men in a 1990 paper in the Journal of Clinical Endocrinology and Metabolism: a hexapeptide GHRP given together with GHRH released far more growth hormone than either did alone. The ghrelin side also needs GHRH tone to perform at full strength, so in models lacking hypothalamic GHRH input, the GHRP response shrinks sharply. Both partners in this blend are short acting, which keeps their timing aligned instead of having one mask the other.

The ratio most people misread

Equal by weight is not equal by molecule count. Ipamorelin weighs about 712 g/mol and Mod GRF about 3368 g/mol, so 5 mg of each works out to roughly 7.0 micromoles of ipamorelin against 1.5 micromoles of the GHRH analogue, close to five ipamorelin molecules for every one of its partner. Anyone reporting molar concentrations, or comparing this vial with a paper that used equimolar amounts, should convert first.

We are often asked for the best peptide to stack with CJC 1295 ipamorelin, and our answer is usually none. A third active compound makes it impossible to tell which receptor produced a change. Design questions involving a third agent are better run from single vials, keeping the blend as a fixed reference arm.

Buy CJC 1295 Ipamorelin Online in Australia for Two Pituitary Pathways in One Vial

The pituitary somatotroph answers two separate signals for growth hormone release. One arrives through the GHRH receptor, the target of Mod GRF (1-29), the stabilised fragment ConjuChem derived from the first 29 residues of human GHRH. The other arrives through GHS-R1a, the ghrelin receptor, which ipamorelin activates. Novo Nordisk scientists described ipamorelin in 1998 as the first GHRP to release growth hormone without notable rises in ACTH or cortisol in the models they tested.

Buy the pair premixed to study how the two pathways add together, a question earlier work answered by reporting a larger release than either agonist produced alone. The vial is a research reagent, not a medicine, and sits in our peptide blends collection next to the other fixed-ratio vials.

CJC 1295 Ipamorelin in Australia Today: One Vial, Two Scheduled Peptides

Both peptides are freeze-dried together, so the vial shows a single white cake rather than two layers, and reconstitution brings them into solution at once. The pairing itself has no developer. Ipamorelin came from Novo Nordisk and the stabilised GHRH fragment from the ConjuChem line of analogues, and the combination grew out of laboratory synergy work and later the overseas clinic trade, never out of a sponsored drug programme. No regulator has approved a medicine holding the two together.

In Australia each ingredient is controlled in its own right. Under the instrument in force in October 2026, the June 2026 Poisons Standard, ipamorelin is named in Schedule 4 and Appendix D, clause 5, while Mod GRF (1-29) falls under the growth hormone releasing hormones class with the same two listings, so mixing them in one vial changes nothing about how either is treated. Neither appears on the ARTG. The TGA has also turned its attention to this corner of the market: on 13 April 2026 it issued an advisory on the responsibilities of anyone importing, compounding or supplying unapproved peptide products, and its compliance priorities for 2026 to 2027 now name unapproved peptides.

The sporting position is doubled as well. WADA's 2026 list catches the GHRH analogue and the ghrelin agonist under two separate headings within class S2, growth hormone releasing factors, so a single vial holds two substances Sport Integrity Australia treats as prohibited at all times.

For researchers asking where to buy CJC 1295 ipamorelin in Australia with both identities documented, the 5 mg plus 5 mg blend is on our Australian shelf now; it goes only to buyers who confirm they are adults, and its sole permitted use is laboratory research, with any human or veterinary application excluded. A single-compound reference for the ghrelin arm is the 10 mg ipamorelin vial.

Order CJC-1295 No DAC Ipamorelin for Sale at 5 mg Plus 5 mg

Order one format, 10 mg of total peptide split evenly, for $65 or $6.50 per mg. Bought separately, CJC-1295 No DAC is $79 for 10 mg and ipamorelin is $59 for 10 mg, so the blend costs less whenever a method needs only 5 mg of each at a matched ratio. Labs that want to vary one compound while holding the other steady should buy the singles and set the ratio themselves.

Several blend vials bought together come from the same lot wherever stock allows, which keeps a full series under one certificate and one set of identity results. Checkout is open to adults aged 18 and over who accept research-only terms.

Shop CJC-1295 and Ipamorelin From Stock With Two Verified Identities

Mod GRF (1-29) carries D-alanine at position 2, glutamine at 8, alanine at 15 and leucine at 27. Those substitutions slow DPP-4 cleavage and give a half-life of about 30 minutes. Ipamorelin, Aib-His-D-2Nal-D-Phe-Lys-NH2, relies on a non-natural aminoisobutyric acid and two D-amino acids to resist breakdown. Neither carries an albumin linker, so both act briefly and their timing lines up.

A blend certificate should show two identity results, a mass near 3367.9 g/mol for the GHRH component and one near 711.9 g/mol for ipamorelin, plus an HPLC trace for the lot. A lot missing either peak is not released. Find your report in the certificate library using the lot number on the label.

Order CJC 1295 Ipamorelin Near You and Keep the Vial Cold

Order online, because there is no retail counter. The blend ships from one local stock to labs across Australia, and payment cleared before 3pm on a business day means dispatch the same day. Teams buying research peptides in Melbourne follow exactly this route. Follow the parcel at any point on the order tracking page.

To reconstitute, bring the vial to room temperature, add bacteriostatic water slowly against the glass and swirl until clear. With 2 mL, the solution carries 5 mg/mL of total peptide, or 2.5 mg/mL of each component. The blend calculator gives both figures for any other volume.

Unopened, the powder keeps at -20 °C in the dark. After mixing, hold it at 2 to 8 °C and use it inside 28 days, divided into aliquots so the stock avoids repeated temperature swings. The peptide storage guide explains why solutions are less stable than powder.

Other Names for the CJC-1295 No DAC and Ipamorelin Blend

Suppliers list the same vial as a CJC-1295 No DAC+Ipamorelin blend, ipamorelin CJC-1295 No DAC, Mod GRF and ipamorelin, or simply the CJC and Ipa blend. The GHRH component also goes by modified GRF (1-29) and tetrasubstituted GRF (1-29), while ipamorelin is sometimes cited by its development code NNC 26-0161.

Receptor terms follow the two pathways. GHRHR is the growth hormone releasing hormone receptor, and GHS-R1a, the growth hormone secretagogue receptor 1a, covers the ghrelin side. Secretagogue simply means a compound that prompts a gland to secrete.

CJC 1295 No DAC Ipamorelin or the Tesamorelin Blend, Which to Order

Both blends add ipamorelin to a GHRH analogue. This one uses the 29 residue Mod GRF fragment at an equal 5 mg plus 5 mg split for $65. The tesamorelin and ipamorelin blend uses the full 44 residue tesamorelin chain at 13 mg plus 3 mg for $129, so its ghrelin input is the minor partner. Order the vial whose analogue and ratio match the protocol.

Some labs build a three-way sermorelin ipamorelin CJC 1295 comparison, setting the native GHRH fragment beside the stabilised one while the ghrelin agonist stays the same. Sermorelin is sold as a 10 mg vial for $89 for that purpose. If the design calls for sustained GHRH stimulation instead of a pulse, neither blend fits, and the long-acting DAC compound is sold on its own.